MongoDB, Inc. is seen as a leader in the GenAI database sector before earnings, according to RBC.

On Wall Street, MongoDB, Inc. (NASDAQ:MDB) is receiving attention as one of the Top 10 AI Stocks. RBC Capital analyst Rishi Jaluria recently reaffirmed an Outperform rating on the company with a $500.00 price target in anticipation of its fourth-quarter fiscal 2026 earnings report. The firm believes that MongoDB is well-positioned for AI-focused application development.

The upcoming earnings report, scheduled for Monday, March 2nd, has led RBC Capital to suggest that MongoDB should be the preferred database provider for creating GenAI and Agentic AI-driven applications.

In preparation for the earnings release, RBC Capital outlined four key areas of interest for investors. These include the potential for continued growth with AI-based customers contributing to the acceleration of Atlas, any commentary on changes in the company’s go-to-market strategy under the new CEO, CJ Desai. Additionally, they are keen on insights into when AI products could begin to positively impact the profit and loss statements through wider adoption of newer AI SKUs which currently do not contribute significantly, as well as initial guidance for fiscal 2027.

Despite a strong performance over the past 12 months, the valuation of MongoDB remains attractive, leading experts to believe that the stock represents a compelling buying opportunity.

MongoDB, Inc. (NASDAQ:MDB) operates a global general-purpose database platform that consolidates operational, unstructured, and AI-related data to facilitate the development of applications efficiently. Despite recognizing the potential of investing in MDB, experts suggest that there are other AI stocks with greater upside potential and lower downside risks.

For investors seeking an undervalued short-term AI stock that could benefit significantly from recent tariffs and the trend towards onshoring, a free report on the best short-term AI stock is recommended.

Looking ahead, MongoDB, Inc. continues to establish itself as a leader in GenAI databases, with the market eagerly awaiting its upcoming earnings report. This company’s focus on AI-driven application development positions it well for future success in the rapidly evolving tech landscape.